Healthcare News

ミネアポリス発, Oct. 22, 2026 (GLOBE NEWSWIRE) -- エッグ・メディカル (Egg Medical) は本日、同社のエッグネスト (EggNest) 強化型放射線防護装置 (ERPD) を評価した前向き研究が「米国心臓協会誌 (Journal of the American Heart Association)」(JAHA) に掲載されたことを発表した。...

미네아폴리스, Oct. 22, 2026 (GLOBE NEWSWIRE) -- 에그 메디컬(Egg Medical)은 자사의 방사선 방호 장치인 에그네스트 강화형 방사선 방호 장치(EggNest Enhanced Radiation Protection Devices, ERPDs)의 성능을 평가한 전향적 연구(prospective study) 결과가...

MINNEAPOLIS, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Egg Medical hari ini mengumumkan penerbitan kajian prospektif dalam Journal of the American Heart Association (JAHA) yang menilai Peranti Perlindungan...

MINNEAPOLIS, Oct. 22, 2026 (GLOBE NEWSWIRE) -- A Egg Medical anunciou a publicação de um estudo prospectivo no Journal of the American Heart Association (JAHA) que avalia que avalia seu Sistema de...

MINNEAPOLIS, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Egg Medical anunció hoy la publicación de un estudio prospectivo en el Journal of the American Heart Association (JAHA) que evalúa sus dispositivos de...

มินนีแอโพลิส, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Egg Medical ประกาศในวันนี้ว่าการศึกษาแบบไปข้างหน้าที่ประเมินอุปกรณ์ป้องกันรังสีขั้นสูง EggNest (ERPDs) ของบริษัท ได้รับการตีพิมพ์ในวารสาร Journal of...

Orphan-drug exclusivity provides seven years of market exclusivity for ONAPGO Additionally, the Company submitted an sNDA to the FDA for a second supplier for ONAPGO, with potential approval by...

Asimov’s CHO Edge System, including Chrysalis transposase and Asimov's genetic design software, will support LG Chem’s cell line development activities.

미국 보스턴, Oct. 22, 2026 (GLOBE NEWSWIRE) -- 치료제 개발을 위한 AI 기반 합성생물학 플랫폼을 구축하고 있는 아시모프(Asimov)는 석유화학, 첨단소재 및 생명과학 분야에서 다양한 사업 포트폴리오를 보유한 글로벌 화학기업 LG화학과 라이선스 계약을 체결했다고 밝혔다. 이번 계약을 통해 LG화학은 아시모프의 CHO Edge...

HOLLISTER, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of...